McCall v. State

487 So. 2d 1375, 1986 Ala. Crim. App. LEXIS 5872
CourtCourt of Criminal Appeals of Alabama
DecidedJanuary 28, 1986
StatusPublished
Cited by4 cases

This text of 487 So. 2d 1375 (McCall v. State) is published on Counsel Stack Legal Research, covering Court of Criminal Appeals of Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McCall v. State, 487 So. 2d 1375, 1986 Ala. Crim. App. LEXIS 5872 (Ala. Ct. App. 1986).

Opinion

Ed McCall was indicted and convicted for the unlawful sale of Preludin in violation of Alabama's Controlled Substances Act. Alabama Code 1975, § 20-2-70. Sentence was twelve years imprisonment and a $7,500 fine.

I
In 1981, the defendant pled guilty to an indictment charging the unlawful sale of "Preludin". Subsequently, that conviction was overturned in 1984 when the circuit court granted a petition for writ of error coram nobis and ordered a new trial. In April of 1984, the defendant was "re-indicted" for the sale of "phenmetrazine". Subsequently, the trial court dismissed this "re-indictment" because of the statute of limitations. The defendant argues that the "re-indictment" in 1984 constituted an abandonment of the indictment returned in 1981. The first two issues raised on this appeal center on the fact that Preludin is the trade name for phenmetrazine which is listed as a Schedule III controlled substance. Alabama Code 1975, §20-2-27 (a)(1)(b). The drug "Preludin" does not appear in any schedule of controlled substances.

Before the defendant's trial, an assistant district attorney informed defense counsel by letter that the 1981 indictments, including the one involved here, would have to be either amended or new indictments returned.

"Anticipating your usual pre-trial motions and demurrer, there are several matters of which you should be aware. It will be necessary to either amend the existing indictments with the consent of the defendant or to present the cases to the June grand jury for re-indictment. The indictments we now have allege the drugs preludin and desoxyn using their *Page 1377 trade names rather than their respective generic names of phenmetrazine and methamphetamine hydrochloride. For your benefit, we will also allege the date of each sale in the amended or new indictments."

"An indictment is not subject to abatement because another charge is pending against the defendant for the same offense.Howard v. State, 29 Ala. App. 199, 194 So. 853, cert. denied,239 Ala. 274, 194 So. 857 (1940). `It is generally held that a grand jury may find a valid indictment notwithstanding another indictment . . . against accused for the same offense. . . .' 42 C.J.S. Indictments Information § 34 (a) (1944)." Clementsv. State, 390 So.2d 1131, 1133 (Ala.Cr.App.), cert. denied,390 So.2d 1136 (Ala. 1980). "The pendency of the two indictments charging the same offense is no ground for abatement of either prosecution." Howard, 29 Ala. App. at 202, 194 So. at 856 (one indictment returned in 1914, the other in 1937).

The defendant had previously pled guilty to the first indictment. Both indictments were apparently the same, the second indictment not being in the record on appeal, except that in one the controlled substance was identified by its trade name while the other indictment employed the generic name.

We do not view the re-indictment of the defendant as an abandonment by the State of its original prosecution, especially since the purpose of the attempted re-indictment was merely to provide the defendant with more particular and specific notice of the original charge. The original indictment was never dismissed or nol-prossed and, as stated above, the existence of a second indictment would not have any effect upon the first.

II
The indictment did charge an offense despite the fact that the controlled substance was described as Preludin, a trade name, rather than phenmetrazine, the generic name for the same drug. The defendant argues that, in charging the sale of a "registered trade mark name of a tablet produced by a pharmaceutical company" instead of describing the controlled substance the way it is listed on the schedule of controlled substances, the indictment failed to state an essential element of the offense and failed to advise the defendant of the exact nature of the offense charged.

"An indictment or information in a prosecution involving narcotics or dangerous drugs must be sufficiently definite with respect to the particular substance involved to enable accused to know with what he is charged." 28 C.J.S.Supp. Drugs Narcotics § 185 (1974).

In Harbor v. State, 465 So.2d 455, 458 (Ala.Cr.App. 1984), cert. quashed, 465 So.2d 460 (Ala. 1985), this Court held that an indictment charging the illegal possession of "Darvon" was not defective because it did not contain the chemical name dextropropoxythene, where a toxicologist testified that Darvon and dextropropoxythene are one and the same drug.

We are not persuaded that Harbor, supra, is due to be overruled, especially in this case, although there is authority that supports the contrary. See Ex parte Holbrook,609 S.W.2d 541, 542-43 (Tex.Cr.App. 1980) (the indictment for fraudulently attempting to obtain possession of "a controlled substance, namely: Preludin" was found invalid because: "The instant indictment should have alleged what facts must be proved about Preludin that make it a controlled substance, and the failure to do so rendered the indictment fundamentally defective").

At the defendant's trial, there was testimony that "Preludin is a brand name for a specific drug, phenmetrazine." * * * "[P]henmetrazine and preludin denote the same preparation, the same drug preparation." At one point in the trial, defense counsel stated, "It's pretty clear that Preludin's the trade name for Phenmetrazine." *Page 1378

Phenmetrazine is listed as a Schedule III controlled substance. Alabama Code 1975, § 20-2-27 (a)(1)(b). The word "Preludin" does not appear on the list of controlled substances. Section 20-2-21 of the Controlled Substances Act provides that "[t]he controlled substances listed or to be listed in the schedules . . . are included by whatever official, common, usual, chemical or trade name designated."

In finding no prejudice to the defendant in this matter, we are guided by the commonsense legislative command that "[w]ords used in a statute to define an offense need not be strictly pursued in the indictment; it is sufficient to use other words conveying the same meaning." Alabama Code 1975, § 15-8-21. While we find no error, we are mindful of Chief Justice Brickell's admonition in Sparrenberger v. State, 53 Ala. 481,482-83, 484-85 (1875):

"It is a well established rule of criminal pleading, that if an offense is purely statutory, the indictment must pursue the words of the statute, so as to bring the defendant precisely within it. There is much conflict of authority as to the precision which must be observed in following the language of the statute. Some authorities require that the exact words of the statute must be employed. Others regard the rule as satisfied if words substantially the same or equivalent — of the same legal import with the words of the statute — are used.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hatcher v. State
936 So. 2d 1104 (Court of Criminal Appeals of Alabama, 2006)
Holland v. State
615 So. 2d 1313 (Court of Criminal Appeals of Alabama, 1993)
Lightfoot v. State
531 So. 2d 57 (Court of Criminal Appeals of Alabama, 1988)
Scarbrough v. State
528 So. 2d 890 (Court of Criminal Appeals of Alabama, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
487 So. 2d 1375, 1986 Ala. Crim. App. LEXIS 5872, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mccall-v-state-alacrimapp-1986.